BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33125621)

  • 1. Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention.
    Villarreal-Garza C; Mesa-Chavez F; Garza-Ledezma MRA; Peña-Curiel O; Martinez-Cannon BA; Canavati-Marcos M; Cardona-Huerta S
    Breast Cancer Res Treat; 2021 Jan; 185(2):453-458. PubMed ID: 33125621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
    Carbognin L; Accetta C; Di Giorgio D; Fuso P; Muratore M; Tiberi G; Pavese F; D'Angelo T; Fabi A; Giannarelli D; Di Leone A; Magno S; Garganese G; Sanchez AM; Terribile DA; Franceschini G; Masetti R; Scambia G; Paris I
    Curr Oncol; 2022 Sep; 29(10):7218-7228. PubMed ID: 36290846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
    Chan A; Bauwens A; Pontre S; Jackson S; McGlone F; Ernenwein T; Chih J; Reid C
    Breast; 2018 Oct; 41():127-132. PubMed ID: 30048865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany.
    Keim S; Hempel L; Ebner F; Retzer-Lidl M; Wohlmuth K; Hempel D; Milani V
    Oncol Res Treat; 2022; 45(7-8):395-399. PubMed ID: 35220298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
    Dilawari A; Gallagher C; Alintah P; Chitalia A; Tiwari S; Paxman R; Adams-Campbell L; Dash C
    Oncologist; 2021 Apr; 26(4):292-e548. PubMed ID: 33512741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
    Vasconcelos I; Wiesske A; Schoenegg W
    Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
    Bajpai J; Kagwade S; Chandrasekharan A; Dandekar S; Kanan S; Kembhavi Y; Ghosh J; Banavali SD; Gupta S
    Breast; 2020 Feb; 49():187-193. PubMed ID: 31865282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
    Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
    Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia.
    Mustoe MM; Lee CM; Melisko ME; Esserman LJ; Rugo HS
    Future Oncol; 2018 Oct; 14(24):2461-2469. PubMed ID: 30001151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
    Tollenaar RA; Liefers GJ; Repelaer van Driel OJ; van de Velde CJ
    Eur J Cancer; 1994; 30A(10):1448-53. PubMed ID: 7833100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
    Macduff C; Mackenzie T; Hutcheon A; Melville L; Archibald H
    Eur J Cancer Care (Engl); 2003 Jun; 12(2):154-61. PubMed ID: 12787013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
    Ridderheim M; Bjurberg M; Gustavsson A
    Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
    Lugtenberg RT; van den Hurk CJG; Smorenburg CH; Mosch L; Houtsma D; Deursen MAGDH; Kaptein AA; Gelderblom H; Kroep JR
    Support Care Cancer; 2022 Aug; 30(8):6641-6648. PubMed ID: 35501515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device.
    Pedersini R; Fornaro C; di Mauro P; Bianchi S; Vassalli L; Amoroso V; Gelmi M; Ardine M; Rodella F; Cosentini D; Dalla Volta A; Turla A; Pierini M; Motta P; Conti E; Simoncini EL; Berruti A
    Int J Nurs Pract; 2021 Jun; 27(3):e12888. PubMed ID: 32959460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
    Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
    Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.